Success story between UAM and FinaBiotech
Success story between UAM and FinaBiotech
FINA BIOTECH has recently obtained a grant from the OEPM (Spanish Patent and Trademark Office) for the promotion of international patent applications and utility models
Fina Biotech has obtained for the 12th consecutive year the grant from the OEPM (Spanish Patent and Trademark Office) for the promotion of international patent applications and utility models. With this grant, the OEPM recognizes once again Fina Biotech´s investing effort in expanding his patent portfolio [...]
Press-release: FINA BIOTECH has successfully validated the results of its bladder cancer diagnostic test in Chinese population
Fina Biotech has successfully validated the previously reported European study results of its bladder cancer diagnostic test in an independent Asian cohort. The prospective blinded study was carried out at the Fudan University Shanghai Cancer Center from 2014-2016 (n=520) to validate four non-invasive tests for BC [...]
Press-release: FINA BIOTECH announces its merger by absorption with BIOFINA DIAGNOSTICS
FINA BIOTECH (acquiring company) has recently completed its merger by absorption with BIOFINA DIAGNOSTICS (acquired company). Both companies took the decision in their respective shareholders´ meeting last June. The combination amplifies FINA BIOTECH´s expertise and capabilities and allows it to better and more efficiently achieve its [...]
Press release – Fina Biotech reinforces its IP portfolio with a new patent in the USA
Fina Biotech announces that the United States Patent and Trademark Office (USPTO) has recently granted patent number 9,902,998 to protect a ´NON-INVASIVE DIAGNOSTIC METHOD FOR DIAGNOSING BLADDER CANCER´. The patent will be in force until January 31st 2034 . The object of this patent relates to [...]
Press release – Biofina Diagnostics is awarded with a Seal of Excellence by the European Commission
Biofina Diagnostics S.L has been recently awarded with a Seal of Excellence by the European Commission following the presentation of its project proposal UROBEST ´UROthelial carcinoma Biomarker based diagnostic tEST´ Submitted under the Horizon 2020’s SME instrument phase 2 call H2020-SMEInst-2016-2017 (topic SMEInst-05-2016-2017) in January 16th [...]
